Tubeimoside II is primarily recognized for its potential in medical research, particularly in the field of cancer therapy. It has shown promising anticancer properties by inducing apoptosis in various cancer cell lines, making it a subject of interest for developing new therapeutic agents. Additionally, it exhibits anti-inflammatory effects, which could be beneficial in treating inflammatory diseases. Researchers are also exploring its antiviral capabilities, especially against certain viruses, to assess its efficacy in antiviral drug development. Its role in traditional medicine has prompted further studies to validate and harness its pharmacological benefits in modern medicine.